MLEC Fundamental Analysis - MOOLEC SCIENCE SA

Fundamental Rating

MLEC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 89 industry peers in the Food Products industry. Both the profitability and financial health of MLEC have multiple concerns. MLEC is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

MLEC had negative earnings in the past year.

MLEC had a negative operating cash flow in the past year.

MLEC had negative earnings in each of the past 5 years.

MLEC had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of MLEC (-237.33%) is worse than 95.51% of its industry peers.

Looking at the Return On Equity, with a value of -600.34%, MLEC is doing worse than 89.89% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-237.33%
ROE	-600.34%
ROIC	N/A

ROA(3y)-73.27%

ROA(5y)N/A

ROE(3y)-207.94%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MLEC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MLEC does not have a ROIC to compare to the WACC, probably because it is not profitable.

There is no outstanding debt for MLEC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -3.94, we must say that MLEC is in the distress zone and has some risk of bankruptcy.

MLEC has a Altman-Z score of -3.94. This is amonst the worse of the industry: MLEC underperforms 83.15% of its industry peers.

A Debt/Equity ratio of 0.03 indicates that MLEC is not too dependend on debt financing.

With a decent Debt to Equity ratio value of 0.03, MLEC is doing good in the industry, outperforming 77.53% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	-3.94

ROIC/WACCN/A

WACC7.5%

2.3 Liquidity

A Current Ratio of 0.26 indicates that MLEC may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.26, MLEC is doing worse than 95.51% of the companies in the same industry.

MLEC has a Quick Ratio of 0.26. This is a bad value and indicates that MLEC is not financially healthy enough and could expect problems in meeting its short term obligations.

MLEC's Quick ratio of 0.22 is on the low side compared to the rest of the industry. MLEC is outperformed by 95.51% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.26
Quick Ratio	0.22

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

EPS 1Y (TTM)N/A

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-20%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%948.41%

3.2 Future

The Earnings Per Share is expected to grow by 17.39% on average over the next years. This is quite good.

MLEC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 106.59% yearly.

EPS Next Y86.74%

EPS Next 2Y37.03%

EPS Next 3Y26.42%

EPS Next 5Y17.39%

Revenue Next Year15.44%

Revenue Next 2Y22.5%

Revenue Next 3Y137.77%

Revenue Next 5Y106.59%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MLEC. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MLEC. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

MLEC's earnings are expected to grow with 26.42% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y37.03%

EPS Next 3Y26.42%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MLEC does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MOOLEC SCIENCE SA

NASDAQ:MLEC (6/20/2025, 8:00:00 PM)

6.77

-1.09 (-13.87%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)06-10 2025-06-10

Earnings (Next)09-30 2025-09-30/bmo

Inst Owners0.37%

Inst Owner ChangeN/A

Ins Owners2.06%

Ins Owner ChangeN/A

Market Cap27.15M

Analysts82.86

Price Target30.6 (351.99%)

Short Float %N/A

Short Ratio0.17

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)37.61%

Min EPS beat(2)1.96%

Max EPS beat(2)73.26%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)900%

PT rev (3m)900%

EPS NQ rev (1m)-900%

EPS NQ rev (3m)-900%

EPS NY rev (1m)0%

EPS NY rev (3m)-900%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	10.26
P/FCF	N/A
P/OCF	N/A
P/B	3.05
P/tB	86.84
EV/EBITDA	N/A

EPS(TTM)-2.2

EYN/A

EPS(NY)-0.24

Fwd EYN/A

FCF(TTM)-2.34

FCFYN/A

OCF(TTM)-2.31

OCFYN/A

SpS0.66

BVpS2.22

TBVpS0.08

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-237.33%
ROE	-600.34%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-73.27%

ROA(5y)N/A

ROE(3y)-207.94%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.12

Health

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.26
Quick Ratio	0.22
Altman-Z	-3.94

F-Score4

WACC7.5%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)N/A

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-20%

EPS Next Y86.74%

EPS Next 2Y37.03%

EPS Next 3Y26.42%

EPS Next 5Y17.39%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%948.41%

Revenue Next Year15.44%

Revenue Next 2Y22.5%

Revenue Next 3Y137.77%

Revenue Next 5Y106.59%

EBIT growth 1Y-189.88%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year80.33%

EBIT Next 3Y25.49%

EBIT Next 5Y21.71%

FCF growth 1Y-506.26%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-498.72%

OCF growth 3YN/A

OCF growth 5YN/A

MOOLEC SCIENCE SA (MLEC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens